Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02778737
Other study ID # K3_K1_0b
Secondary ID
Status Active, not recruiting
Phase N/A
First received May 12, 2016
Last updated May 20, 2016
Start date September 2013
Est. completion date July 2016

Study information

Verified date May 2016
Source University of Cyprus
Contact n/a
Is FDA regulated No
Health authority Cyprus: Cyprus National Bioethics Committee
Study type Interventional

Clinical Trial Summary

Chronic pain is a long-term condition which is related to a number of negative consequences including reduced productivity at work, increased number of sick leave , depression and emotional difficulties among others. Psychological interventions, particular Cognitive Behavioral therapies (CBT) are deemed effective in reducing the negative consequences following a diagnosis of a chronic pain condition. Though research provides substantial evidence for the CBT effectiveness, not all patients manage to reduce pain intensity or improve their physical and psychosocial functioning. Also, CBT appears with only small effect sizes on variables considered to be core domains in chronic pain. Finally, there are criticism targets on the lack of clear mechanisms underlying the process of change in CBT.

New CBT therapeutic approaches, such as Acceptance and Commitment Therapy (ACT) focus on changing individuals' relation with their inner experiences. They utilize mindfulness and acceptance processes, instead of directly changing or controlling the content of internal experiences, as CBT does. ACT has received support for its effectiveness in chronic pain but there are very few clinical randomized trials to compare it with traditional CBT.

The purpose of this study is to determine whether an ACT-based intervention when compared with a CBT-based intervention designed for chronic pain patients is efficacious in reducing pain interference, pain-related disability, and psychological distress. Also this study aims to examine whether any therapeutic effects result due to the effect of acceptance, for those participating in the ACT group or control appraisal, for those participating in the CBT group. Better knowledge of the mechanism of therapeutic change can help us to recognize which patients can be benefit from which approach.


Description:

For more than 30 years cognitive behavior therapy has been the mainstream treatment approach for chronic pain patients and research evidence supporting its effectiveness . Review demonstrate that CBT for chronic pain leads in lowered pain, less emotional distress and pain-related disability, reduced medication use and healthcare utilization, and better improvement in physical and psychosocial functioning. Though CBT for chronic pain is effective, recent evidence suggest that not all patients succeed in lowering pain or improving their physical and psychosocial functioning. Also, research shows only small effects on disability and criticisms targets on the lack of clear mechanisms underlying the process of change in CBT. Researchers argue that the problem with CBT effectiveness lies on its methods. CBT attempts to manage various problems that chronic pain patients face utilizing different methods in combination. This expansion of CBT methods has created concerns among researchers and clinicians as it is not clear what works for whom. More comprehensive and integrated theoretical models encompassing various pain coping responses call for new research that can buffer the CBT expansion.

Following the CBT criticisms, new treatment approaches stemming from the third wave of cognitive behavior therapy abandon traditional approaches to directly change or control the content of internal experiences, and give more emphasis on changing individuals' relation with their inner experience. In doing so, they use mindfulness and acceptance approached along with value-committed actions to produce behavioral changes. One of these approaches, known as Acceptance and Commitment Therapy, has extensively researched in the area of chronic pain and recently the division 12 of the APA listed ACT as an empirically treatment with strong research support for general chronic pain conditions. Indeed, ACT has received amounting evidence in chronic pain and research outcomes demonstrate strong effects on physical and psychosocial disability, mood and daily functioning. Though ACT has received support for its effectiveness in chronic pain, there are yet very few clinical randomized trials to compare it with traditional CBT.

The primary aim of the Algea study is to investigate the efficacy of an ACT-based intervention designed for general chronic pain patients and compare it with a CBT intervention. Specific hypotheses include: (1) ACT will demonstrate improvements in pain indices (pain severity and interference), psychological distress, and quality of life when compared with the CBT group; (2) ACT will present with long-term effects (i.e., 6 months) and patients will report better satisfaction with this treatment than the CBT group; and (3) pain acceptance and values-based actions are considered mechanism of change variables that mediate treatment response in ACT, while control appraisal will mediate treatment response in CBT.

Better knowledge of the differences and similarities of the two CBT approaches (i.e., traditional CBT for chronic pain and ACT) in managing chronic pain can help us formulate treatments that can be tailored to patients needs.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 200
Est. completion date July 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Presentation of chronic pain episodes

- Significant impact of the chronic pain condition on quality of life

- Having a medical diagnosis of chronic pain

- Stable medical treatment for at least 2 months

- Reading ability sufficient to comprehend self-monitoring forms as well as competence in the Greek language

Exclusion Criteria:

- An active non pharmacologically-controlled psychotic spectrum condition or manic episode, suicidal ideation/ intent or substance use problems within the 6 months prior to recruitment

- Having a severe medical condition in the present (e.g. cancer)

- No significant cognitive impairment, as assessed using the Mini-mental Status Examination (MMSE).

- Age under 18 or above 70 years

- Receiving any other psychological intervention which is based on CBT

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
ACT-based intervention
Treatment sessions will be conducted weekly by two co-therapists in groups of approximately 8-10 participants for 1 ½ hours. Although each session has specific objectives, therapists within the time frame, are encouraged to accommodate participants' discussion or other group dynamic issues that may arise. Participants will receive their AP-ACT handbook including outlines of each session, activity plan assignments, and a CD with recorded mindfulness exercises. Session highlights and AP-ACT activities relevant to each session will be given at each meeting, so that participants will follow along with the treatment protocol. Individuals missing more than two consecutive sessions will be considered as dropouts.
CBT-based intervention
Treatment sessions will be conducted weekly by two co-therapists in groups of approximately 8-10 participants for 1 ½ hours. Although each session has specific objectives, therapists within the time frame, are encouraged to accommodate participants' discussion or other group dynamic issues that may arise. Participants will receive their AP-CBT handbook including outlines of each session, activity plan assignments, and a CD with recorded relaxation exercises. Session highlights and AP-CBT activities relevant to each session will be given at each meeting, so that participants will follow along with the treatment protocol. Individuals missing more than two consecutive sessions will be considered as dropouts.

Locations

Country Name City State
Greece University of Crete Rethymnon Crete

Sponsors (2)

Lead Sponsor Collaborator
University of Cyprus University of Crete

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Other Changes in the levels of pain acceptance as assessed via the Greek Chronic Pain Acceptance Questionnaire (G-CPAQ; Vasiliou, Karekla, Michaelides, & Kasinopoulos, under review) The G-CPAQ assesses pain acceptance and consists of 20 items (long version) of which 8-items comprise the short version. It is rated on a 7-point Likert scale (0 = "never true" to 6 = "always true") and yields a total sum with a range from 0-120. Higher scores denote greater pain acceptance. The G-CPAQ presents with sufficient construct validity when assessed with scales considered theoretically related and appears with high reliability (Cronbach's alpha: Total score = .76; AE =.86; PW = .69 for the G-CPAQ-8). Changes in pain acceptance from baseline through study completion, an average of 1 year No
Other Changes in avoidance of pain levels as assessed via the Greek version of the Psychological Inflexibility in Pain Scale (G-PIPS-II; Vasiliou, Karekla, Michaelides, & Kasinopoulos, in preparation; Wicksell, Lekander, Sorjonen & Olsson, 2010) The G-PIPS-II contains 12 items assessing pain-related avoidance. Items are rated on a 7-point Likert-type scale, with 1="never true" and 7="always true". Higher scores indicate higher avoidance of pain. The scale shows good psychometric properties (Wicksell et al. 2010) with high internal consistency (Cronbach's a=.88) and validity with associated constructs in its Greek version. The PIPS-II scale is frequently used a a coping with pain scale assessing pain avoidance. Changes in pain avoidance from baseline through study completion, an average of 1 year No
Other Changes in experiential avoidance as assessed via the Acceptance and Action Questionnaire- Greek version (AAQ-II; Karekla & Michaelides, under review) The Acceptance and Action Questionnaire- Greek version is a 7-item measure of experiential avoidance or an individual efforts to systematically avoid or control unwanted internal experiences such as thoughts, emotions, bodily sensations etc (Hayes et al, 2004). It uses a Likert-type scale ranging from 1="never true" to 7="always true". Higher scores indicate greater experiential avoidance. The measure demonstrated good psychometric properties (Cronbach's alpha=.83) and a unidimensional factor structure in its original version (Bond et al., 2011). Also, validation of the AAQ-II in the Greek language present with similar with its english counterpart psychometric properties (alpha=.92). Changes in experiential avoidance from baseline through study completion, an average of 1 year No
Other Changes in mindfulness as assessed via the Cognitive Affective Mindfulness Scale-Revised (CAMS-R; Feldman, Hayes, Kumar, Greeson, & Laurenceau, 2007) The CAMS-R is a 12 item questionnaire assessing mindfulness. Items are rated on a 4-point Likert scale from 1="rarely" to 4="almost always". Cronbach's alpha ranges from .74 to .77 (Feldman et al., 2007). CAMS-R presents with high reliability (a = .81) and sufficient construct validity as assessed with theoretically related constructs. A Greek version appears with similar to its English counterpart unitary factor structure, high reliability (a =.88) and sufficient construct validity with other theoretically-related scales. Changes in mindfulness levels from baseline through study completion, an average of 1 year No
Other Changes in goal-directed behaviors as assessed via the Committed Action Questionnaire (CAQ; McCracken et al., 2014) CAQ is an 8-item scale assesses goals- directed behaviors (McCracken, 2014). Items are ranged from 0 = never true to 6 = always true, and higher scores denote higher committed actions. CAQ presents with high internal consistency reliability (a = .87) and sufficient validity with other related instruments, including pain acceptance, depression, and functioning (McCracken et al., 2014). Changes in goal-directed behaviors from baseline through study completion, an average of 1 year No
Other Changes in living composite values as assessed via the Valued Living Questionnaire (VLQ; Wilson, Sandoz, Kitchens, & Roberts, 2010) VLQ assesses individuals' values and the degree to which they live consistently with these values in their everyday life. It consists of two factors (i.e. importance and consistency). Respondents are asked to rate 10 areas of life (e.g. family, relationships, work, education etc.) on a scale of 1= the worst level of important/ consistency in each domain and 10= the highest level of importance/ consistency in each domain. The living composite which represents the degree to which a person lives and behaves in accordance to chosen values, is calculated by summing the importance and consistency responses for each item (Wilson, 2008). Preliminary studies demonstrate that the VLQ has adequate reliability a = .74 (Wilson et al., 2010). Reliability of the Greek version of the VLQ is high for both factors (Importance: a = .81; Consistency: a =.87) and the living composite total score (a =.89; Stavrinaki, Siamata, Vasiliou, Karekla & Kasinopoulos, 2013). Changes in living composite values levels from baseline through study completion, an average of 1 year No
Primary Change in pain intensity as assessed with the Greek Brief Pain Inventory (G-BPI) is an 11-item measure of intensity and interference of pain in 7 life dimensions: work, mood, activity, sleep, relationships, walking and enjoyment, rated on a scale with 0="no pain" and 10="pain as bad as you can imagine". The G-BPI has shown good reliability, Cronbach's alpha=.80 and sufficient validity with constructs considered theoretically related. Change from baseline pain intensity through study completion, an average of 1 year No
Secondary Change in the Quality of life as assessed with the Short Form Health Survey (SF-36; Greek version 1.0; Pappa, Kontodimopoulos & Niakas, 2005) The SF-36 is a 36 items multipurpose measure assessing physical and mental health indexes. It yields a total score indicating a general health index. SF-36 uses a Likert-type scale and higher scores indicate better overall quality of life. The SF-36 is widely used in clinical studies and evidence across studies indicate that it presents with high validity when compared with theoretically related scales. Also across studies SF-36 yields sufficinet chronbach alpha reliability. Change in levels of QoL from baseline through study completion, an average of 1 year No
Secondary Change in insomnia as assessed with the Athens Insomnia Scale (AIS; Soldatos, Digeos, Paparrigopoulos, 2000) The AIS is an 8 item scale assessing difficulty with sleep induction, awakenings during the night, early morning awakening, total sleep time, and overall quality of sleep. It uses a Likert-type scale with items ranging from 0= no problem at all to 3= serious problem. AIS has a long and brief version.The long version utilizes the entire eight-item scale (AIS-8) with a total score ranging from 0 (i.e., absence of any sleep-related problem) to 24 (i.e. the most severe degree of insomnia) and assesses a full range of insomnia symptoms reflecting the disorder as it is described in the ICD-10. The brief five-item version (AIS-5) is limited to the first five items, and yields a total score ranged from 0 to 15. AIS-5 evaluates difficulties with sleep quantity and quality. The AIS (both versions) demonstrates good convergent validity when assessed with theoretically related scales and excellent reliability (a=.89 for the AIS-8 and a=.88 for the AIS-5). Change in insomnia from baseline through study completion, an average of 1 year No
Secondary Change in the levels of psychological distress as assessed with the Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) HADS is a 14 item questionnaire assessing levels of anxiety and depression symptomatology. Each subscale consists of 7 items rated on a 4-point scale (0-3). Higher scores indicate greater psychological distress. The Greek version presents with high internal consistency (Cronbach's alpha=.88) and sufficient validity when compared with scales considered theoretically related (Michopoulos et al., 2008). Changes in the levels of psychological distress from baseline through study completion, an average of 1 year No
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain